Back to Search
Start Over
[Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
- Source :
-
Duodecim; laaketieteellinen aikakauskirja [Duodecim] 2011; Vol. 127 (3), pp. 235-42. - Publication Year :
- 2011
-
Abstract
- Breast cancer is a heterogenous disease and hormonal factors are involved. Since national differences exist in the use of postmenopausal hormone therapy (HT) and other risk factors, associations between HT and breast cancer should be studied nationally. In Finland, estrogen-progestin therapy is associated with higher breast cancer risk than estrogen-only therapy. Also tibolone and levonorgestrel releasing intauterine device combined with estrogen are accompanied with an increased risk of breast cancer. Hormone therapy possibly promotes the growth of the existing undetectable cancer.
- Subjects :
- Aged
Contraceptive Agents, Female adverse effects
Estrogen Receptor Modulators adverse effects
Female
Finland epidemiology
Humans
Intrauterine Devices adverse effects
Levonorgestrel adverse effects
Middle Aged
Norpregnenes adverse effects
Risk Factors
Breast Neoplasms chemically induced
Breast Neoplasms epidemiology
Estrogen Replacement Therapy adverse effects
Postmenopause
Subjects
Details
- Language :
- Finnish
- ISSN :
- 0012-7183
- Volume :
- 127
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Duodecim; laaketieteellinen aikakauskirja
- Publication Type :
- Academic Journal
- Accession number :
- 21438346